Catherine Bollard - Jun 3, 2024 Form 4 Insider Report for Cabaletta Bio, Inc. (CABA)

Role
Director
Signature
/s/ Michael Gerard, Attorney-in-Fact
Stock symbol
CABA
Transactions as of
Jun 3, 2024
Transactions value $
$0
Form type
4
Date filed
6/4/2024, 07:27 PM
Previous filing
Jun 2, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CABA Stock Option (Right to Buy) Award $0 +22K $0.00 22K Jun 3, 2024 Common Stock 22K $10.01 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest in full upon the earlier of (i) June 3, 2025 or (ii) the date of the next annual meeting of the Corporation's stockholders.